Searchable abstracts of presentations at key conferences in endocrinology

ea0016p741 | Thyroid | ECE2008

Pharmacokinetics of digoxin in hyperthyroidism: effect of methimazole and acebutolol

Gasinska Teresa , Izbicka Maria , Dec Renata

Hyperthyroid patients show an impaired response or even resistance to digoxin treatment.Objectives: 1. Are there any differences in the pharmacokinetics of a single oral dose of digoxin between hyperthyroid and euthyroid patients? 2. Does simultaneous administration of digoxin and methimazole or digoxin and acebutolol affect the pharmacokinetics of a single oral dose of dogoxin? 3. Does methimazole-induced euthyroidism change the pharmacokinetics of a si...

ea0016p742 | Thyroid | ECE2008

Iodine metabolism and effect of 131I therapy in Graves’ disease

Kijek Jolanta , Tarach Jerzy S , Kurowska Maria

The factors influencing the final outcomes of 131I therapy are indefinitely known, besides its practical use since more than 60 years. One of the considered factors affecting the results of 131I therapy is iodine metabolism.Aim: The aim of the study was the evaluation of the iodine uptake and the effective half-life of 131I influence on the result of radioactive iodine therapy in patients treated due to Graves’ hyper...

ea0014p326 | (1) | ECE2007

Partial withdrawal of levothyroxine to stimulate serum thyroglobulin (TG) in the follow-up of differentiated thyroid carcinoma (DTC)

Ianni Francesca , Rota Carlo Antonio , Corsello Salvatore Maria , Rosa Annapina De , Gallo Francesca , Paragliola Rosa Maria , Ingraudo Francesca , Ricciato Maria Pia , Maussier Maria Ludovica , Salvatori Massimo , Pontecorvi Alfredo

Aim: We compared effectiveness of partial withdrawal of levothyroxine (L-T4) to the use of recombinant human TSH (rhTSH) in preparation for Tg testing. We also evaluated clinical aspects and quality-of-life (QOL) during both regimens.Materials and methods: Ten consecutive patients, previously treated with total thyroidectomy and radioiodine ablation for DTC, underwent rhTSH protocol and, after 15 days, reduced their L-T4 dose by 50% for 5 weeks. At the f...

ea0014p493 | (1) | ECE2007

Five-year treatment experience with metformin in polycystic ovary syndrome

Petrányi Gyula , Zaoura Maria

In 2002, we introduced metformin as an alternative treatment option of the anti-androgenic contraceptive pill in polycystic ovary syndrome (PCOS). The analysis of our observations is presented here.170 women (age 14–45 y) were diagnosed with PCOS according to the Rotterdam criteria. 88% had acne, 68% hirsutism, 46% irregular menstrual cycles, 39% BMI over 25 kg/m2, 13.5% had apple-type obesity and 4.7% acanthosis nigricans. 104/170 patien...

ea0014p577 | (1) | ECE2007

Midnight salivary cortisol vs. urinary free cortisol for the diagnosis of Cushing’s syndrome

Yaneva Maria , Kirilov Georgi , Zacharieva Sabina

Introduction: Midnight salivary cortisol measurement (MSC) has been recently introduced as a diagnostic test for hypercortisolism. The aim of our study was to compare the diagnostic value of two methods of screening for Cushnig’s syndrome (CS): MSC and 24-h urinary free cortisol (UFC), wildely accepted as a ‘gold standard’ for this diagnosis.Patients and methods: Three groups were studied: 30 patients with CS (mean age±S.D.</sm...

ea0056p385 | Diabetes (to include epidemiology, pathophysiology) | ECE2018

Gestational diabetes – association of lipid profile in pregnancy with post-partum dysglycemia

Paredes Silvia , Fernandes Aline , Pereira Maria Lopes

Introduction: Lipid profile characterization in women with gestational diabetes mellitus (GDM) and its impact on post-partum dysglycemia remains to elucidate. The aim of this study was to evaluate lipid profile in women with GDM during pregnancy and 8 weeks after and to study its correlation with glycemic control.Methods: This study was carried out in a central hospital in Portugal. All women with GDM diagnosed from January/2014 to December/2015 were enr...

ea0056p511 | Diabetes therapy | ECE2018

Effects of opuntia ficus-indica plant extract ingestion on glucose and insulin plasma levels during oral glucose tolerance test

Christou Maria , Markozannes Georgios , Tigas Stelios

Background: Cladodes of the nopal opuntia streptacantha (prickly-pear cactus) have been traditionally used for the treatment of diabetes in Mexico. Limited data from studies in experimental animals and humans with prediabetes or type 2 diabetes (DM2), have shown promising antihyperglycemic effects using plant extracts of the streptacantha and ficus-indica opuntia species. The purpose of this study was to assess the effect of opuntia ficus-indica<...

ea0056p990 | Clinical case reports - Thyroid/Others | ECE2018

Sunitinib induced myxedema in a patient with metastatic gastrointestinal stromal tumor (GIST)

Popa Maria Lavinia , Ursu Ioan Horea

Introduction: It is known that hypothyroidism has multiple etiologies including tyrosinkinase inhibitors (TKI) agents which can cause thyroid disfunction through different mecanisms, not fully defined yet- Vascular endothelial growth factor receptor (VEGFR) blockade, thyroiditis, iodine uptake blockade, increased activity of deiodinase 3, increased hormone clearance. Some recent trials suggest that there is a correlation between the incidence of hypothyroidism and the outcome ...

ea0056ep70 | Diabetes, Obesity and Metabolism | ECE2018

Controversies of endocrine treatment in Prader-Willi syndrome: a case report of two monozygotic twins

Gomes Vania , Ferreira Florbela , Bugalho Maria Joao

Introduction: Prader-Willi syndrome (PWS) is a neurobehavioral imprinting disorder, which arises due to an absence of paternally expressed genes within the 15q11.2-q13 region. It is the most common syndromic form of obesity, with an estimated prevalence of about 1 in 25,000 individuals.Case report: we report the case of two monozygotic twins, 20-year-old, naturally conceived, both affected by PWS. They were born by eutocic delivery at 34 weeks of gestati...

ea0073pep8.6 | Presented ePosters 8: Pituitary and Neuroendocrinology | ECE2021

Can the follow-up imaging interval for non-functioning pituitary microadenomas be extended?

Han Ashley , Varlamov Elena , Fleseriu Maria

BackgroundData on clinical characteristics and natural history of patients with non-functioning pituitary microadenomas (NFPmA) is limited to small-scale studies.MethodsA retrospective evaluation of initial clinical presentation and natural history of patients with NFPmA (conservatively managed, years; 2004–2020) was undertaken. Initial symptoms, tumor size, and pituitary function were assessed. Exclusio...